Funding news
HMNC Brain Health logo

HMNC Brain Health Closes $50.

Recently funded · $50.0M Series bHospitals and Health CareDEView source

Get the full HMNC Brain Health company profile

Access contacts, investors, buying signals & more

Open in Dashboard

A Munich-based biotech aiming to personalize treatment for neuropsychiatric disorders, HMNC Brain Health, has secured $50.0M in Series B funding. The precision medicine pioneer, which focuses on depression, announced the capital infusion from investor MEDICE.

Founded in 2010, HMNC Brain Health combines machine learning-enabled companion diagnostics with specific therapeutics. Its approach involves developing patented genetic tests and pairing them with innovative, exclusively in-licensed medications to create precise therapies, ultimately seeking to reduce the immense individual and societal burden of these diseases.

From the source

Slava · Jun 15, 2026

The Day in AI Funding — Monday, June 15, 202620 fresh AI and automation financings totaling at least ~$778.4M disclosed.Plus 1 YC reveal.GROWTH & INFRASTRUCTURE ROUNDS→ Sarvam AI — $234M first close of a planned $300M Series B at a $1.5B valuation, led by HCLTech.

India-focused sovereign AI lab building LLMs and full-stack AI infrastructure.→ Genspark — $100M Series B extension, bringing the round to $485M at a $2.6B valuation. All-in-one AI workspace automating knowledge-work tasks.→ Hydra Host — $100M funding, including a Nvidia-backed Series A. GPU infrastructure management platform for data centers and AI compute.→ NewCore — $66M Seed, led by Cyberstart

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other Germany companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
X-BIONIC® logo

X-BIONIC®

Switzerland

$65.0M
2
GWI logo

GWI

United Kingdom

$180.0M
3
Bdeo logo

Bdeo

Spain

$8.2M
4
pymetrics (now Harver) logo

pymetrics (now Harver)

United States

$40.0M
5
Amaryllis logo

Amaryllis

United States

$10.0M